Literature DB >> 9645211

[Predictive significance of reflex otalgia in local radical radiotherapy of oropharyngeal carcinomas].

K T Beer1, C von Briel, T Lampret, S Marré, D Vetterli, P Zbären, R H Greiner.   

Abstract

BACKGROUND: Patients with carcinomas of the upper aero-digestive tract often suffer from ear pain as a tumor associated syndrome. This prospective study examines the predictive and prognostic value of this symptom. PATIENTS AND METHODS: Ninety-six consecutive patients who completed a locally radiotherapy of a carcinoma of the oropharynx were prospectively evaluated and followed. Forty-nine out of 96 patients stated the symptom, either spontaneously or after questioning. The 2 groups showed no difference regarding TNM-classification, histology and total dose. Overall survival, local control and disease specific survival were calculated according to Kaplan-Meier and compared by the log-rank test.
RESULTS: A clinically complete remission was obtained in significantly fewer patients with reflex-otalgia as compared to patients without reflex-otalgia, 61.2% versus 89.3%, p < 0.002. Local control of patients with reflex-otalgia was significantly less with 49%, mean follow-up 564 days, in comparison to local control in patients without reflex-otalgia, mean follow-up 613 days, p = 0.01. Disease specific survival was significantly worse for patients with reflex-otalgia, p < 0.012. The probability of local control of T1/T2 tumors with reflex-otalgia was similar to T3/T4 tumors without reflex-otalgia. Local control for all tumor categories combined is 74% for patients without reflex-otalgia versus 49% for patients with reflex-otalgia.
CONCLUSION: In our patients, reflex-otalgia is a new and statistically significant parameter for the probability of local control and disease specific survival.

Entities:  

Mesh:

Year:  1998        PMID: 9645211     DOI: 10.1007/bf03038544

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy.

Authors:  P Zbären; W Lehmann
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-07

2.  [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].

Authors:  N Zamboglou; H Pape; T Schnabel; R Wurm; B Bannach; G Fürst; G Schmitt
Journal:  Strahlenther Onkol       Date:  1989-09       Impact factor: 3.621

3.  [The results of simultaneous radio-chemotherapy in advanced head and neck tumors].

Authors:  T G Wendt; T P Wustrow; A Schalhorn
Journal:  Strahlenther Onkol       Date:  1990-09       Impact factor: 3.621

4.  [Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors].

Authors:  R Fietkau; H Iro; G G Grabenbauer; A Altendorf-Hofmann; R Sauer
Journal:  Strahlenther Onkol       Date:  1991-12       Impact factor: 3.621

5.  Follow-up data of our pilot study on concomitant hyperfractionated radiotherapy and cisplatinum (CDDP) in patients with advanced cancer of the head and neck.

Authors:  C Glanzmann; U M Lütolf
Journal:  Strahlenther Onkol       Date:  1992-08       Impact factor: 3.621

6.  Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Authors:  M Merlano; M Benasso; R Corvò; R Rosso; V Vitale; F Blengio; G Numico; G Margarino; L Bonelli; L Santi
Journal:  J Natl Cancer Inst       Date:  1996-05-01       Impact factor: 13.506

  6 in total
  1 in total

1.  Ear pain in patients with oropharynx carcinoma: how MRI contributes to the explanation of a prognostic and predictive symptom.

Authors:  Harriet C Thoeny; Karl T Beer; Peter Vock; Richard H Greiner
Journal:  Eur Radiol       Date:  2004-05-01       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.